Redirected killing of FcγR+ P815 cells in the presence of anti-NKp30 and anti-NKp46 mAbs showed a reduced degranulation of NK cells in COVID-19 patients (42.95±18.69% vs. 0.31 ±8.53%; p<0.01, U-test; Fig 4A and 4B). The gene discussed is NCR1; the disease is COVID-19.